Causaly Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 135

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $60M

  • Investors
  • 22

Causaly General Information

Description

Developer of a biomedical platform designed to find evidence, explore hidden connections, and make new predictions in biomedical science. The company's platform allows anyone to run deep searches and find the answers to complex research questions that would have previously taken weeks or even months to find with traditional keyword search, enabling clients to discover new insights and accelerate research work and human discovery in biomedicine.

Contact Information

Website
www.causaly.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 10 - 16 Elm Street
  • London WC1X 0BJ
  • England, United Kingdom
+44 07538
Primary Industry
Enterprise Systems (Healthcare)
Other Industries
Discovery Tools (Healthcare)
Vertical(s)
Artificial Intelligence & Machine Learning, HealthTech
Corporate Office
  • 10 - 16 Elm Street
  • London WC1X 0BJ
  • England, United Kingdom
+44 07538

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Causaly Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series B) 20-Jun-2023 $60M Completed Generating Revenue
5. Early Stage VC (Series A3) 20-Sep-2022 Completed Generating Revenue
4. Early Stage VC (Series A2) 18-May-2021 Completed Generating Revenue
3. Accelerator/Incubator 01-Jan-2021 Completed Generating Revenue
2. Early Stage VC (Series A) 18-Oct-2019 $4.8M $6M Completed Generating Revenue
1. Seed Round 02-Jul-2018 $1.2M $1.2M Completed Generating Revenue
To view Causaly’s complete valuation and funding history, request access »

Causaly Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B
Series A-3
Series A-2
Series A 4,335,335 $0.000010 $1.11 $1.11 1x $1.11 13.9%
Seed 2,612,969 $0.000010 $0.46 $0.46 1x $0.46 8.38%
To view Causaly’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Causaly Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a biomedical platform designed to find evidence, explore hidden connections, and make new predictions in bi
Enterprise Systems (Healthcare)
London, United Kingdom
135 As of 2026

Manchester, United Kingdom
 

New York, NY
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Causaly Competitors (3)

One of Causaly’s 3 competitors is Biorelate, a Venture Capital-Backed company based in Manchester, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Biorelate Venture Capital-Backed Manchester, United Kingdom
Prognos Health Venture Capital-Backed New York, NY
Saama Analytics Venture Capital-Backed Campbell, CA
You’re viewing 3 of 3 competitors. Get the full list »

Causaly Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Causaly Investors (22)

Investor Name Investor Type Holding Investor Since Participating Rounds
ICONIQ Growth Venture Capital Minority
Visionaries Club Venture Capital Minority
Amity Ventures Venture Capital Minority
Angel (individual) Minority
Index Ventures Venture Capital Minority
You’re viewing 5 of 22 investors. Get the full list »

Ready to get started?

Request a free trial

Causaly FAQs

  • When was Causaly founded?

    Causaly was founded in 2018.

  • Where is Causaly headquartered?

    Causaly is headquartered in London, United Kingdom.

  • What is the size of Causaly?

    Causaly has 135 total employees.

  • What industry is Causaly in?

    Causaly’s primary industry is Enterprise Systems (Healthcare).

  • Is Causaly a private or public company?

    Causaly is a Private company.

  • What is the current valuation of Causaly?

    The current valuation of Causaly is .

  • What is Causaly’s current revenue?

    The current revenue for Causaly is .

  • How much funding has Causaly raised over time?

    Causaly has raised $93.1M.

  • Who are Causaly’s investors?

    ICONIQ Growth, Visionaries Club, Amity Ventures, , and Index Ventures are 5 of 22 investors who have invested in Causaly.

  • Who are Causaly’s competitors?

    Biorelate, Prognos Health, and Saama Analytics are competitors of Causaly.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process